The following is a summary of "Clinicopathologic and genomic analyses of SMARCA4-mutated non-small cell lung carcinoma ...

There are two types of SCLC, which are based on which cells are affected: Small-cell carcinoma, which is also called oat cell cancer, is the more common type of SCLC. Combined small-cell carcinoma ...

Source: Getty Images At an early stage, basal cell carcinoma is small and confined, and usually can be cured. When the cancer gets larger and grows deeper in the skin or spreads to other organs ...

Small-cell lung cancer is a highly malignant form of lung cancer, also known as oat-cell carcinoma, that accounts for approximately 15% of lung cancer cases. Composed of small, ovoid cells with ...

Small-cell lung cancer (SCLC), sometimes called small-cell carcinoma, causes about 10%-15% of all lung cancer. Non-small-cell lung cancer (NSCLC) causes the rest. Both include many types of ...

1 Department of Obstetrics and Gynecology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China 2 Department of Pathology, The Second Affiliated Hospital, ...

Doctors stage non-small cell lung cancer (NSCLC) according to how far it has progressed. Stages range from occult (or hidden) cancer to stage 4 cancer, in which multiple organs may be affected.

The incidence and mortality rates of lung cancer are high worldwide, where non-small cell lung cancer (NSCLC) accounts for more than 85% of lung cancer cases. Recent non-small cell lung cancer ...

Real-world community oncology-based treatment patterns for first line axitinib plus pembrolizumab in advanced renal cell carcinoma: Initial dosing, dose reductions and clinical outcomes. Efficacy and ...

Non-small cell lung cancer that has metastasized may cause different symptoms depending on where it has spread. Treatment can help reduce symptoms and prolong life. Non-small cell lung cancer ...

More information: Ling Cai et al, High Glucose Contribution to the TCA Cycle Is a Feature of Aggressive Non–Small Cell Lung Cancer in Patients, Cancer Discovery (2025). DOI: 10.1158/2159-8290.CD ...